Cas no 13379-98-1 (N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide)
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide Chemical and Physical Properties
Names and Identifiers
-
- Benzenesulfonamide, N-(3-hydroxypropyl)-4-methyl-
- CS-0036430
- SY125745
- MFCD00458992
- N-(3-hydroxy-propyl)-4-methylbenzenesulfonamide
- N-(3-HYDROXYPROPYL)-4-METHYL-1-BENZENESULFONAMIDE
- AS-68143
- N-(3-hydroxypropyl)-4-methylbenzene-1-sulfonamide
- N-(3-hydroxypropyl)-4-methylbenzenesulfonamide
- SCHEMBL4703731
- AKOS005141054
- W10842
- OXBINBPGHTWHKS-UHFFFAOYSA-N
- N-(3-Hydroxy-propyl)-4-methyl-benzenesulfonamide
- DB-431820
- Z57800717
- 13379-98-1
- STK288078
- Cambridge id 5279758
- N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide
-
- MDL: MFCD00458992
- Inchi: 1S/C10H15NO3S/c1-9-3-5-10(6-4-9)15(13,14)11-7-2-8-12/h3-6,11-12H,2,7-8H2,1H3
- InChI Key: OXBINBPGHTWHKS-UHFFFAOYSA-N
- SMILES: S(C1C=CC(C)=CC=1)(NCCCO)(=O)=O
Computed Properties
- Exact Mass: 229.07735
- Monoisotopic Mass: 229.07726451g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 15
- Rotatable Bond Count: 5
- Complexity: 263
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 74.8?2
Experimental Properties
- PSA: 66.4
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | H952653-10mg |
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide |
13379-98-1 | 10mg |
$ 50.00 | 2022-06-04 | ||
| TRC | H952653-50mg |
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide |
13379-98-1 | 50mg |
$ 115.00 | 2022-06-04 | ||
| TRC | H952653-100mg |
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide |
13379-98-1 | 100mg |
$ 185.00 | 2022-06-04 | ||
| abcr | AB462106-250 mg |
N-(3-Hydroxy-propyl)-4-methyl-benzenesulfonamide; . |
13379-98-1 | 250mg |
€308.40 | 2023-04-21 | ||
| abcr | AB462106-1 g |
N-(3-Hydroxy-propyl)-4-methyl-benzenesulfonamide; . |
13379-98-1 | 1g |
€698.70 | 2023-04-21 | ||
| eNovation Chemicals LLC | D762456-100mg |
Benzenesulfonamide, N-(3-hydroxypropyl)-4-methyl- |
13379-98-1 | 95% | 100mg |
$55 | 2024-06-06 | |
| eNovation Chemicals LLC | D762456-250mg |
Benzenesulfonamide, N-(3-hydroxypropyl)-4-methyl- |
13379-98-1 | 95% | 250mg |
$65 | 2024-06-06 | |
| eNovation Chemicals LLC | D762456-1g |
Benzenesulfonamide, N-(3-hydroxypropyl)-4-methyl- |
13379-98-1 | 95% | 1g |
$100 | 2024-06-06 | |
| eNovation Chemicals LLC | D762456-5g |
Benzenesulfonamide, N-(3-hydroxypropyl)-4-methyl- |
13379-98-1 | 95% | 5g |
$275 | 2024-06-06 | |
| eNovation Chemicals LLC | Y1216425-1g |
N-(3-Hydroxypropyl)-4-methylbenzenesulfonamide |
13379-98-1 | 95% | 1g |
$500 | 2023-09-03 |
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide Related Literature
-
Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
-
Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
-
Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
Additional information on N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide (CAS No. 13379-98-1): An Overview of Its Properties, Applications, and Recent Research
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide (CAS No. 13379-98-1) is a versatile compound with significant applications in various fields, including pharmaceuticals, chemical synthesis, and materials science. This comprehensive overview delves into the chemical properties, synthesis methods, biological activities, and recent research advancements of this compound.
Chemical Properties
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide is a white crystalline solid with a molecular formula of C10H15NO3S and a molecular weight of 225.29 g/mol. The compound features a sulfonamide functional group attached to a substituted benzene ring and a hydroxylated propyl chain. These structural characteristics contribute to its unique physicochemical properties, such as solubility in polar solvents and reactivity in various chemical reactions.
The compound exhibits good thermal stability and can be stored under standard laboratory conditions. Its melting point is reported to be around 165-167°C, and it has a moderate solubility in water and organic solvents like ethanol and dimethyl sulfoxide (DMSO). These properties make it suitable for use in a wide range of applications.
Synthesis Methods
The synthesis of N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 4-methylbenzenesulfonyl chloride with 3-amino-1-propanol in the presence of a base such as triethylamine. This reaction proceeds via nucleophilic substitution, yielding the desired product with high purity.
Another approach involves the coupling of 4-methylbenzenesulfonamide with 3-chloropropanol using a suitable catalyst. This method offers good yields and is particularly useful for large-scale production. Recent advancements in green chemistry have led to the development of more environmentally friendly synthesis methods, such as the use of microwave-assisted reactions and catalytic systems that minimize waste generation.
Biological Activities
N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide has been extensively studied for its biological activities, particularly in the context of pharmaceutical applications. One of its notable properties is its ability to act as an inhibitor of specific enzymes involved in metabolic pathways. For instance, it has shown potential as an inhibitor of carbonic anhydrase, an enzyme implicated in various physiological processes such as pH regulation and ion transport.
Recent research has also explored its anti-inflammatory and analgesic properties. Studies have demonstrated that N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide can effectively reduce inflammation in animal models by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest its potential use in the development of new therapeutic agents for inflammatory diseases.
Clinical Applications
The potential clinical applications of N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide are diverse and promising. In addition to its anti-inflammatory properties, the compound has been investigated for its potential use in pain management. Preclinical studies have shown that it can provide effective analgesia without significant side effects, making it an attractive candidate for further clinical trials.
Ongoing research is also exploring its role in neuroprotection. Preliminary studies suggest that N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide may have neuroprotective effects by reducing oxidative stress and preventing neuronal cell death. These findings could have significant implications for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Recent Research Advancements
The field of medicinal chemistry continues to advance our understanding of N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide. Recent studies have focused on optimizing its pharmacokinetic properties to enhance its therapeutic efficacy and reduce potential side effects. For example, researchers have developed prodrug forms that improve bioavailability and target delivery to specific tissues or organs.
In addition to these efforts, computational methods such as molecular docking and molecular dynamics simulations are being employed to predict the binding interactions between N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide and its target proteins. These computational tools provide valuable insights into the molecular mechanisms underlying its biological activities and guide the design of more potent analogs.
Conclusion
In conclusion, N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide (CAS No. 13379-98-1) is a multifaceted compound with significant potential in pharmaceuticals and other scientific fields. Its unique chemical structure confers valuable physicochemical properties that make it suitable for various applications. Ongoing research continues to uncover new biological activities and clinical applications, highlighting its importance in modern medicine and materials science.
13379-98-1 (N-(3-Hydroxy-Propyl)-4-Methyl-Benzenesulfonamide) Related Products
- 2619-22-9(p-toluenesulfonamide, n-(2-cyanoethyl)-)
- 15544-47-5(benzenesulfonamide, n,n'-butylenebis[4-methyl-)
- 1907-65-9(N-butyl-4-methylbenzene-1-sulfonamide)
- 23705-38-6(Benzenesulfonamide,4-methyl-N-(2-methylpropyl)-)
- 1133-12-6(4-methyl-N-propylbenzene-1-sulfonamide)
- 56125-49-6(N-(3-Aminopropyl)-4-methylbenzenesulfonamide)
- 805338-72-1(Benzenesulfonamide,N-[(2R)-2-hydroxypropyl]-4-methyl-)
- 59724-53-7(N-(2-Hydroxypropyl)-4-methylbenzenesulfonamide)
- 53364-99-1(n,n'-di-p-tosyl-1,3-diaminopropane)
- 871113-52-9([1,1'-Biphenyl]-4-sulfonamide, N-(3-hydroxypropyl)-)